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Background
This interesting case highlights the clinical progression of a rare
disease process and the important role of a multi-disciplinary
team in achieving a diagnosis and successful management plan.

Case Presentation
A 76-year-old male with a history of coronary artery disease,
hypertension and hyperlipidemia presented as an outpatient
with left foot pain and swelling. He had spent a week bicycling
in Colorado one month prior to presentation. The pain was
initially localized to the plantar surface of his foot and progressed
to involve the lateral and dorsal aspects of the foot, as well as his
great toe. The pain was accompanied by swelling of the midfoot
without erythema and he was unable to bear weight. His podiatrist
prescribed Ibuprofen and a foot brace for empiric treatment of
tendonitis. An outpatient MRI demonstrated extensive bony
edema and synovial enhancement within the midfoot, as well
as severe superficial edema and peroneal tendonitis with mild
subluxation. The patient was sent to the emergency department
to be evaluated for osteomyelitis.
On exam, the patient was afebrile with normal vital signs. The
left foot was warm and edematous without erythema or discrete
fluid collection. There were no ulcers or breaks in the skin. The
dorsal portion of the foot was exquisitely tender to palpation. The
ankle had decreased active and passive range of motion. Pedal
pulses were equal, and sensation was intact. Initial chemistries
were significant for an erythrocyte sedimentation rate (ESR) of
81 mm/hr and C reactive protein (CRP) of 1.1 mg/dL. Foot and
ankle x-rays were negative for fracture or dislocation. Venous
ultrasound of the lower extremities was negative for deep venous
thrombosis.
The patient was evaluated by orthopedic surgery and was
diagnosed with severe bony stress and trauma from his prolonged
bike trip. A full rheumatologic evaluation was normal. A fluid
collection amenable to arthrocentesis was not identifiable. Based
on imaging and physical exam, the Infectious Disease team did
not feel there was evidence of osteomyelitis. The patient was
prescribed high-dose Ibuprofen to treat inflammation caused
by bony trauma and placed in an air boot. The patient’s pain and
edema improved and he was discharged.
Two weeks later, the patient presented with worsening left foot
pain, edema, and continued inability to bear weight. He was
noted to have new left calf atrophy, but proximal and distal
muscles of the legs had full strength. Laboratory results were
significant for a leukocytosis of 11.7 B/L, CRP of 2.2 mg/dL, and
ESR of 94 mm/hr. A left foot x-ray demonstrated progression
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of left foot swelling, osteoporosis, and intertarsal joint erosions.
An MRI of the lumbosacral spine to evaluate for nerve root
compression did not identify any mass or abnormal signal
along the lumbosacral plexus. An MRI of the left foot and ankle
demonstrated unchanged bone marrow edema. No drainable
fluid collection was identified, and there was no evidence of
osteomyelitis. A bone scan demonstrated abnormal activity
within the left midfoot consistent with neuropathic joint disease
and synovitis of the left knee. Orthopedic surgery was consulted,
and additionally diagnosed micro-fractures of the midfoot,
visible on the left foot x-ray and MRI. Their diagnosis was
neuropathic joint disease and they recommended non-weightbearing status for joint preservation.
The patient developed progressive left knee edema and posterior
tenderness to palpation. An ultrasound of the left leg and ankle
demonstrated a Baker cyst, as well as chondrocalcinosis in
the cartilage of the talar dome and extensive synovitis of the
talonavicular and tarsometatarsal joints (Figures 1,2). Results
were discussed with Neurology and Radiology and a diagnosis
of pseudogout of the left knee, foot and ankle was made.
Rheumatology recommended high dose scheduled Naproxen.
The patient’s pain and edema improved, and he was discharged
home with Naproxen and an orthopedic boot.

Outcome and Follow-up
Two weeks after discharge, rheumatology aspirated three
milliliters of straw-colored fluid from the left ankle, which
contained calcium pyrophosphate crystals, consistent with
pseudogout. An ultrasound four months later demonstrated
improvement in the left talonavicular and tarsometatarsal joint
synovitis, and a small tibiotalar joint effusion with persistent
chondrocalcinosis. The patient’s outpatient orthopedic surgeon
confirmed the diagnosis of pseudogout, with associated pseudoneuropathic joint disease. The patient is currently being
maintained on low dose scheduled Naproxen and Methotrexate
as an outpatient. He is no longer wearing an orthopedic boot,
and is progressively regaining his mobility.

Discussion
This case highlights the importance of an evolving differential
diagnosis, based on physical exam, laboratory and radiological
tests. The initial outpatient differential diagnosis included severe
multifocal stress response, osteomyelitis, and early neuropathic
change, and evolved to include reflex sympathetic dystrophy,
osteoporosis and finally pseudogout with associated neuropathic
joint disease.
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Figure 1. Color Doppler Ultrasound, sagittal view of Figure 2. Ultrasound, sagittal view through the tibiotalar joint, showing
the talonavicular joint, showing thickened synovium cartilage calcification (arrow) at the talar dome, diagnostic of chondrocalcinosis
and increased color Doppler flow, indicating synovitis.
Calcium pyrophosphate dehydrate (CPPD) crystal deposition,
and ensuing crystal-induced synovitis, is an important pathologic
entity that is part of a spectrum of disease. This includes
pseudogout, or acute attacks of CPPD synovitis, chondrocalcinosis, or radiographically evident deposition of CPPD crystals,
and CPPD arthropathy, or chronic joint disease that typically
accompanies CPPD crystal deposition. This disease process
has important epidemiologic implications, as estimates suggest
an age-related rise in prevalence of related chondrocalcinosis.1
CPPD crystal formation is thought to initiate near the surface
of chondrocytes and may be related to purely elevated levels
of calcium, pyrophosphate, or local cartilage matrix changes
that enhance calcium or pyrophosphate levels. Most cases are
idiopathic, but some are associated with an underlying disorder.
Hemochromatosis, hyperparathyroidism, hypophosphatemia,
hypomagnesemia, familial hypocalciuric hypercalcemia,
Gitelman’s syndrome, gout, and hypothyroidism have been
shown to be associated with CPPD. Joint trauma or joint instrumentation is also an important etiology.2,3
Definitive diagnosis of CPPD crystal deposition disease is
made by synovial fluid analysis. Microscopy of aspirated fluid
will demonstrate the presence of positively birefringent CPPD
crystals. CPPD crystal deposits can be imaged by plain film
radiography as linear radiodensities in joint cartilage, ligaments
and joint capsules.4 Ultrasound imaging can also be used to
diagnose CPPD deposition disease. CPPD crystals will appear as
hyperechoic bands along the cartilage surface or as hyperechoic
spots in the fibrocartilage.5
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There are few cases of CPPD crystal deposition disease associated
with severe joint degeneration resembling neuropathic
arthropathy and Charcot joint. This rare condition that has
been termed “pseudo-neuropathic joint disease.” It has been
speculated that acute episodes of pseudogout and chondrocalcinosis can precede the development of Charcot arthropathy
through cartilaginous microfractures, which results in the
shedding of CPPD crystals into the joint cavity and progressive
joint destruction.6-8
In patients with acute CPPD crystal arthritis, the CPPD crystals
should be removed by arthrocentesis. Intra-articular injection of
glucocorticoids is recommended in patients with no more than
two involved joints. When more than two joints are involved,
administration of oral non-steroidal anti-inflammatory (NSAID)
medications is recommended. For patients in whom NSAIDs
are contraindicated, colchicine can be used, and in patients for
whom NSAIDs and colchicine are contraindicated, systemic
glucocorticoids or immunomodulators such as methotrexate
can be used. Joint immobilization is the mainstay of therapy
for pseudo-neuropathic joint disease in order to prevent the
development of microfractures and joint collapse.9

Key Points
Pseudo-neuropathic pseudogout is a rare disease process that
can be difficult to elucidate. The key to diagnosis is arthrocentesis of the involved joint and the identification of calcium
pyrophosphate crystals in the synovial fluid. Ultrasound is a
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sensitive and specific technique for identifying chondrocalcinosis in a patient with suspected neuropathic joint disease.
The mainstay of treatment is NSAID therapy.
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